ValiRx plc (LON:VAL – Get Free Report)’s stock price traded down 6.8% during trading on Tuesday . The stock traded as low as GBX 0.68 ($0.01) and last traded at GBX 0.70 ($0.01). 5,912,103 shares traded hands during trading, a decline of 65% from the average session volume of 16,815,768 shares. The stock had previously closed at GBX 0.75 ($0.01).
ValiRx Stock Performance
The firm’s 50-day moving average price is GBX 0.91 and its 200 day moving average price is GBX 1.57. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.27 and a current ratio of 6.65. The company has a market cap of £925,126.50, a price-to-earnings ratio of -34.95 and a beta of 0.59.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Find and Profitably Trade Stocks at 52-Week Lows
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Why Are These Companies Considered Blue Chips?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
